Compared to LUAD components, SCLC and LCNEC tumors, both of which are high-grade NEC, demonstrated upregulation of pathways associated with cell proliferation including G2M, E2F, and MYC consistent with the high proliferative nature of SCLC and LCNEC44. Here, MYC is linked to small cell lung carcinoma.